Inhibition of HDAC1,2 activity leads to a more rapid cell death compared to inhibition of EZH2 activity alone, suggesting that factors in addition to H3K27me3 might contribute to the chemoresistance in EZH2GOF DLBCL. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.